Land: Australien
Sprache: Englisch
Quelle: Department of Health (Therapeutic Goods Administration)
fexofenadine hydrochloride, Quantity: 180 mg
Cipla Australia Pty Ltd
Fexofenadine hydrochloride
Tablet, film coated
Excipient Ingredients: magnesium stearate; croscarmellose sodium; povidone; microcrystalline cellulose; maize starch; titanium dioxide; hypromellose; iron oxide yellow; macrogol 4000; macrogol 400
Oral
30 tablets, 7 tablets, 70 tablets, 20 tablets, 50 tablets, 10 tablets
(S2) Pharmacy Medicine
Relief of the symptoms associated with seasonal allergic rhinitis or urticaria in adults and children 12 years or older.
Visual Identification: Yellow oblong biconvex film coated tablet plain on one side, central breakline in the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2007-05-25